Bottom line
ARKG vs HELX: the short answer
ARKG (ARK Genomic Revolution ETF) and HELX (Franklin Genomic Advancements ETF) are quite different portfolios: only about 26% of their top holdings (by weight) are shared.
HELX is cheaper at 0.5% vs 0.75% — a difference of $25 a year per $10,000 invested.
Over five years, HELX returned −3.8% a year vs −6.5% for ARKG (reporting dates differ).
Updated Nov 19, 2026
ARKG vs HELX side by side
| ARKG | HELX | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | ARK Invest | Franklin Templeton |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.75% | 0.5% |
| Annual cost per $10k | $75 | $50 |
| 10-yr cost on $10k (prospectus) | $930 | $629 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | −28.1% | +25.9% |
| 5-yr return (annualized) | −6.5% | −3.8% |
| 10-yr return (annualized) | +1.9% | — |
| Best quarter | +66.0% | +19.6% |
| Worst quarter | −31.5% | −23.7% |
| Net assets (fund) | $1.6B | $27.9M |
| Number of holdings | 33 | 63 |
| Portfolio turnover | 33% | 29% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | ARKG | HELX | Difference |
|---|---|---|---|
| 2024 | −28.1% | −5.1% | −23.0% |
| 2023 | +16.2% | +1.2% | +15.0% |
| 2022 | −53.9% | −37.9% | −16.1% |
| 2021 | −33.9% | +9.7% | −43.6% |
Source: Fund prospectus bar charts
Holdings overlap
8 of ARKG's top 25 holdings also appear in HELX's top 25.
| Holding | ARKG | HELX |
|---|---|---|
| Twist Bioscience Corp | 7.73% | 2.85% |
| Tempus Ai Inc | 6.56% | 1.95% |
| Guardant Health Inc | 4.74% | 9.09% |
| Eli Lilly & Company | 4.68% | 2.95% |
| Natera Inc | 4.13% | 7.46% |
| Adaptive Biotechnologies Corp | 2.57% | 3.99% |
| Veracyte Inc | 2.55% | 1.64% |
| Ionis Pharmaceuticals Inc | 1.77% | 1.91% |
Source: SEC Form N-PORT
ARKG top 10
- 10x Genomics Inc — 9.39%
- Twist Bioscience Corp — 7.73%
- Tempus Ai Inc — 6.56%
- Crispr Therapeutics Ag — 6.29%
- Personalis Inc — 5.47%
- Absci Corp — 5.14%
- Guardant Health Inc — 4.74%
- Illumina Inc — 4.74%
- Eli Lilly & Company — 4.68%
- Caredx Inc — 4.30%
HELX top 10
- Guardant Health Inc — 9.09%
- Natera Inc — 7.46%
- Krystal Biotech Inc — 6.33%
- Ligand Pharmaceuticals Inc — 4.62%
- Adaptive Biotechnologies Corp — 3.99%
- United Therapeutics Corp — 3.51%
- Bridgebio Pharma Inc — 3.50%
- Eli Lilly & Company — 2.95%
- Twist Bioscience Corp — 2.85%
- Vertex Pharmaceuticals Inc — 2.75%
FAQ
What is the difference between ARKG and HELX?
Which is cheaper, ARKG or HELX?
Should I own both ARKG and HELX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.